By: Haidy Marzouk, MD, MBA, FAAOA In honor of kids ENT month, the AAOA would like to highlight a topic very important to our pediatric allergy population. Anaphylaxis occurs in about 1.6%-5.1% of the US population.(1) Although known as a…
FDA Approves First Generic Version of EpiPen
The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr.
FDA Commissioner Scott Gottlieb, M.D states that “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages…”